Open access · CC-BY
via OpenAlex
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Min S. Wang, Shanta P. Boddapati, Sharareh Emadi, Michael R. Sierks
BMC Neuroscience · 2010 · ▲ 200 citations
Abstract
BACKGROUND: Overexpression and abnormal accumulation of aggregated alpha-synuclein (alphaS) have been linked to Parkinson's disease (PD) and other synucleinopathies. alphaS can misfold and adopt a variety of morphologies but recent studies implicate oligomeric forms as the most cytotoxic species. Both genetic mutations and chronic exposure to neurotoxins increase alphaS aggregation and intracellular reactive oxygen species (ROS), leading to mitochondrial dysfunction(definition) and oxidative damage in PD cell models. RESULTS: Here we show that curcumin can alleviate alphaS-induced toxicity, reduce ROS levels and protect cells against apoptosis. We also show that both intracellular overexpression of alphaS and extracellular addition of oligomeric alphaS increase ROS which induces apoptosis, suggesting that aggregated alphaS may induce similar toxic effects whether it is generated intra- or extracellulary. CONCLUSIONS: Since curcumin is a natural food pigment that can cross the blood brain barrier and has widespread medicinal uses, it has potential therapeutic value for treating PD and other neurodegenerative disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/1471-2202-11-57
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Wang, M.S., Boddapati, S.P., Emadi, S., & Sierks, M.R. (2010). Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model. <em>BMC Neuroscience</em>. https://doi.org/10.1186/1471-2202-11-57
Vancouver
Wang MS, Boddapati SP, Emadi S, Sierks MR. Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neuroscience. 2010. doi:10.1186/1471-2202-11-57.
BibTeX
@article{min2010Curcum,
title = {Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model},
author = {Min S. Wang and Shanta P. Boddapati and Sharareh Emadi and Michael R. Sierks},
journal = {BMC Neuroscience},
year = {2010},
doi = {10.1186/1471-2202-11-57},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Synapse 2017
Citation only
Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration
Journal of Alzheimer s Disease 2006
Citation only
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
Movement Disorders 2018
Open access · CC-BY
Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
International Journal of Molecular Sciences 2020
Open access · CC-BY
Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer’s Disease
Drug Design Development and Therapy 2017
Open access · CC-BY
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Antioxidants 2023
Open access · CC-BY